Specific blood immune response to haemophilus in stable COPD patients

L. Millares, M. Garcia-Nuñez, A. Marin, M. Sabria, J. Morera, S. Alberti, E. Monso (Badalona (Barcelona), Spain)

Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host
Session: Mechanisms of respiratory infections: interaction between the pathogen and the host
Session type: Thematic Poster Session
Number: 2282
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstract

Abstract

Aim: To investigate the specific blood immune response to Haemophilus in patients with stable COPD.
Methods : We collected clinical information, sputum and serum from 13 COPD patients in a 18 months PILOT cohort study with follow-up visits scheduled every 9 months. Serum antibodies to Haemophilus were detected with whole bacterial cell ELISA. Data of IgA, IgG and IgM were corrected with a pool of healthy controls serum samples and were analyzed according to the isolated microorganisms and their changes between visits.
Results : The results of IgA, IgG and IgM levels were 1.40±0.35, 1.25±0.23 and 1.07±0.25 at baseline visit. We observed a correlation IgG:IgA (Pearson correlation coefficient [r], 0.443; p<0.05) and IgG:IgM ([r], 0.541; p<0.01) levels. No differences in the IgG, IgA or IgM levels of Haemophilus-specific response were found according to the Haemophilus species isolated in each visit. Nonetheless, in patients with a positive culture for H. influenzae, IgM response was correlated with IgA (Pearson c.c. [r], 0.541; p<0.05) and IgG ([r], 0.791; p<0.01) whereas, when H. parainfluenzae was the microorganism isolated, the IgA response was correlated with IgG (Pearson c.c. [r], 0.874; p<0.01).
Follow-up study: When the same PFGE pattern was isolated between 2 visits, levels of Haemophilus-specific IgA (t test, p=0.027) and IgM (p>0.05) were increased, but not IgG levels that remained stable. Moreover, when no Haemophilus species were isolated in the follow-up visit, levels of IgG and IgM decreased, but not IgA levels.
Conclusions : Persistent bronchial colonization by Haemophilus in stable COPD patients is associated with a specific blood immune response mainly IgA and IgM mediated
Funded by FIS06/0684.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Millares, M. Garcia-Nuñez, A. Marin, M. Sabria, J. Morera, S. Alberti, E. Monso (Badalona (Barcelona), Spain). Specific blood immune response to haemophilus in stable COPD patients. Eur Respir J 2008; 32: Suppl. 52, 2282

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary and systemic cellular immune response network in patients with mild-moderate COPD
Source: International Congress 2017 – Systemic and airway biomarkers
Year: 2017

Evaluation of specific immune complexes in patients with pulmonary sarcoidosis.
Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Year: 2018


Changes parameters of non-specific immune defence during COPD exacerbation
Source: Eur Respir J 2004; 24: Suppl. 48, 511s
Year: 2004

Assessment of humoral immune response and the incidence of acquired infections in asthmatic children
Source: Eur Respir J 2003; 22: Suppl. 45, 174s
Year: 2003

CD4+ T cell responses to non-encapsulated Haemophilus influenzae in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: Suppl. 45, 350s
Year: 2003

Humoral immune response to influenza vaccination in silicosis patients
Source: Eur Respir J 2006; 28: Suppl. 50, 695s
Year: 2006

Lung and blood Th1 and Th17 responses against mycobacterial antigens in patients with pulmonary sarcoidosis
Source: Annual Congress 2011 - T-cell subsets
Year: 2011


Assessment of innate immunity mediators in the lung of COPD patients: relation with disease manifestations
Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity
Year: 2020


Activation of immune cell proteasomes in peripheral blood of smokers and COPD patients: implications for therapy
Source: Eur Respir J, 59 (3) 2101798; 10.1183/13993003.01798-2021
Year: 2022



Anti-endotoxin humoral immunity in patients with pneumonia
Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention
Year: 2008


Differences in systemic immune function contribute to exacerbation susceptibility in COPD patients
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015


Effects of pneumococcal vaccine in patients with chronic respiratory disease
Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Year: 2007


Effects of pneumococcal vaccine in patients with chronic respiratory disease
Source: Eur Respir Rev 2008; 17: 43-45
Year: 2008



The assessment of immune cells profile in blood and induced sputum in patients with COPD developing lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 674s
Year: 2006

Role of adaptive immunity in clinical variability of active tuberculosis patients
Source: Virtual Congress 2021 – Novel imaging analysis methodologies in diffuse lung diseases
Year: 2021


Organised local immune response in the lungs of patients with tuberculosis
Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Year: 2009

Infection pattern and inflammatory response in acute and persistent nontypeable haemophilus influenzae (NTHi) infection of COPD lung tissue
Source: Eur Respir J 2006; 28: Suppl. 50, 841s
Year: 2006

Alteration of the immune response to nontypeable haemophilus influenzae (NTHI) during COPD exacerbation in mice
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013

Increased uptake of haemophilus influenzae by primary airway epithelial cells from COPD patients
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016